Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin vs Low FODMAP Diet in IBS-D
NCT03219528Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Feb 2018
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifaximin in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by University of Michigan. Started Feb 2018; status: completed.
02
Drugs
rifaximin
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT03219528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03219528.